EMERGENT BIOSOLUTIONS INC. Current Income Tax Expense (Benefit)
EMERGENT BIOSOLUTIONS INC. (EBS) reported Current Income Tax Expense (Benefit) of $34.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-27
- EMERGENT BIOSOLUTIONS INC. current income tax expense (benefit) for fiscal 2025 was $34.10M, a 35.90% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. current income tax expense (benefit) for fiscal 2024 was $53.20M, a 45.36% increase from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. current income tax expense (benefit) for fiscal 2023 was $36.60M, a 39.16% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. current income tax expense (benefit) for fiscal 2022 was $26.30M, a 35.38% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $34.10M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $53.20M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $36.60M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $26.30M 10-K · filed 2025-03-04 | $26.00M 10-K · filed 2023-03-01 |
| 2021-12-31 | $40.70M 10-K · filed 2024-03-08 | $39.60M 10-K · filed 2022-02-25 |
| 2020-12-31 | $109.50M 10-K/A · filed 2023-12-11 | $104.50M 10-K · filed 2021-02-19 |
| 2019-12-31 | $24.00M 10-K · filed 2022-02-25 | |
| 2018-12-31 | $10.20M 10-K · filed 2021-02-19 | |
| 2017-12-31 | $32.70M 10-K · filed 2020-02-25 | $32.78M 10-K · filed 2018-02-23 |
| 2016-12-31 | $32.50M 10-K · filed 2019-02-22 | $32.58M 10-K · filed 2017-02-28 |
| 2015-12-31 | $43.21M 10-K · filed 2018-02-23 | $23.43M 10-K · filed 2016-02-29 |
| 2014-12-31 | $24.77M 10-K · filed 2017-02-28 | $11.00M 10-K · filed 2015-03-09 |
| 2013-12-31 | -$751.00K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $10.54M 10-K · filed 2015-03-09 | |
| 2011-12-31 | -$4.83M 10-K · filed 2014-03-10 | |
| 2010-12-31 | $16.95M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |